IMMUcan Upstream SCCHN3 cohort

The goal of IMMUcan is to understand how the immune system interacts with tumors and how therapeutic interventions influence this interaction. This cohort includes patients from the UPSTREAM trial, with squamous cell carcinoma of the head and neck (SCCHN) cancer which has spread (metastatic) or the tumour has come back after previous treatment (recurrent). Comprehensive profiling data are integrated with longitudinally collected clinical information. Cellular profiling of the same tumor samples was performed using multiplex immunofluorescence imaging, imaging mass cytometry, and H&E staining.

Type: Cancer Genomics
Archiver: European Genome-Phenome Archive (EGA)

2 Datasets

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID	Description	Technology	Samples
EGAD50000002178	Tumor versus Germline variant calling on UPST-SCCHN3 cohort	Illumina Genome Analyzer II Illumina NovaSeq 6000	460
EGAD50000002179	Transcriptomics of Tumor samples on UPST-SCCHN3 cohort	Illumina Genome Analyzer II	217